Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.

A. Beltramello, M. Leonardi, E. Biasizzo, G. Piscitelli

Research output: Contribution to journalArticle


Results of a clinical trial in CT myelocisternography performed with a new reduced concentration of iopamidol (150 mg I/ml) are reported. This compound is characterized by very low osmolality and osmotic pressure close to those of blood and CSF. Thirty patients were examined. Before, during and after the procedure pulse rate and blood pressure were recorded, EEG was taken and neurologic examination performed. After the examination no alteration in these parameters was recorded. The demonstration of the subarachnoid space and related structures was invariably adequate for diagnosis. In no case was a repeat study using a higher concentration of contrast medium needed. Mild reactions occurred only in three patients (10%). The authors conclude that iopamidol 150, owing to its safety and good imaging capacity, is useful in CT imaging of the subarachnoid space.

Original languageEnglish
Pages (from-to)542-544
Number of pages3
JournalActa Radiologica, Supplement
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of 'Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.'. Together they form a unique fingerprint.

  • Cite this